Press release Malmö, August 19, 2021 Acarix AB (publ) publishes Interim Report, January - June 2021 Continued positive trend with focus on US expansion The second quarter continued
On June 30, 2021, the shares in Inzile AB (publ) (the "Company") were given
observation status on the grounds that the Company had entered into an
agreement to acquire shares in QEV Tech Holdings S.L and
STOCKHOLM, SWEDEN - August 12, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the US Food and Drug Administration (FDA) has issued a clinical hold for Aprea Therapeutics
STOCKHOLM, Aug. 5, 2021 /PRNewswire/ Continued strong growth SECOND QUARTER 2021 Sales grew 22.1% to EUR 209.2 million, organic growth amounted to 11.2% and acquired growth
Nasdaq Stockholm AB: Last day of trading in Sdiptech AB (publ) (287/21)
At the request of Sdiptech AB (publ), the trading in the company s B-shares and
preference shares on Nasdaq First North Premier Growth Market is to cease. As
from June 11, 2021, the shares will be listed on Nasdaq Stockholm.
Last day of trading is today on June 10, 2021.
Short name: SDIP B
ISIN code: SE0003756758
Order book ID: 137416
Short name: SDIP PREF
ISIN code: SE0006758348
Order book ID: 106736
For further information concerning this exchange notice please contact Listing
Qualifications, telephone +46 8 405 60 00, or iss@nasdaq.com.
Kostenloser Wertpapierhandel auf Smartbroker.de